re: Ann: Pharmaxis Announces Positive Combine... And we must also keep in mind that a second phase 3 trial is currently active for the use of Bronchitol for bronchiectasis.
There are approx. 600,000 sufferers worldwide with no drug currently proven effective to clear mucus.
Although this trial is not expected to release data until 2012, there is the potential that with a favourable outcome Bronchitol would be approved for this indication as well.
The potential really is great for this medication.
Ann: Pharmaxis Announces Positive Combined Phase , page-13
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.003(13.6%) |
Mkt cap ! $29.85M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.8¢ | 2.4¢ | $51.56K | 1.911M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1166606 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 230000 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| SNT (ASX) Chart |